A pilot study to evaluate the efficacy and safety of pegylated interferon alfa-2b [peginterferon alpha-2b] plus ribavirin in the treatment of patients with dual chronic hepatitis B and delta,
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis B; Hepatitis D
- Focus Therapeutic Use
- 25 May 2006 Biomarkers information updated
- 16 Nov 2005 New trial record.